Stockreport

Immunome's experimental drug meets main goal in late-stage study [Yahoo! Finance]

Immunome, Inc.  (IMNM) 
PDF The oral drug, varegacestat, is ?being tested ?in patients with desmoid tumors, also known ?as aggressive fibromatosis or desmoid-type fibromatosis, that are aggressive [Read more]